The present study investigated the effects of arachidonic acid on Torp
edo (alpha beta gamma delta) and neuronal nicotinic acetylcholine (ACh
) receptors (chick alpha 7; rat alpha 7, alpha 3 beta 2, alpha 3 beta
4, alpha 4 beta 2, and alpha 4 beta 4). Arachidonic acid (10 mu M) dep
ressed currents through normal Torpedo ACh receptors during treatment
and afterward, persistently (greater than or equal to 30 min) potentia
ted the currents. The potentiation was blocked by the selective protei
n kinase C (PKC) inhibitor, GF109203X or PKC inhibitor peptide (PKCI).
The depression was not inhibited by any protein kinase inhibitor exam
ined here, but greater in Ca2+-free extracellular solution. Arachidoni
c acid also potentiated currents through mutant Torpedo ACh receptors
lacking PKC phosphorylation sites at Ser333 on the alpha subunit and S
er377 on the delta subunit without depression, but otherwise, it depre
ssed currents through mutant receptors replacing of each Ser by negati
vely charged amino acid residue, possibly that mimics PKC phosphorylat
ion of the receptors. These results suggest that the depression was du
e to the direct blocking effect on Ca2+-modulatory sites, which was ac
celerated under conditions of the receptors phosphorylated by PKC, and
that the potentiation was caused by PKC activation, independently of
PKC phosphorylation of the receptors. Arachidonic acid reduced current
s through chick alpha 7 receptors by a mechanism independent of protei
n kinase activation. In contrast, arachidonic acid potentiated current
s through rat alpha 7, alpha 3 beta 2, alpha 4 beta 2, and alpha 4 bet
a 4 receptors, perhaps by the same mechanism as the potentiation obser
ved in Torpedo ACh receptors, although it had no effect on rat alpha 3
beta 4 receptors. The results of the present study thus demonstrate t
hat arachidonic acid exerts diverse actions on nicotinic ACh receptors
by different mechanisms. (C) 1998 Elsevier Science B.V. All rights re
served.